A retrospective study on parapneumonic effusion in 130 dogs with a clinical diagnosis of pneumonia [PDF]
ObjectiveTo screen the occurrence of parapneumonic effusion in dogs.MethodsMedical records were searched for dogs with a presumptive diagnosis of bacterial pneumonia from 2017 to 2021 at the Liege university teaching hospital.
Priscilla Burnotte +2 more
doaj +3 more sources
Long-Term Outcomes of Necrotizing Pneumonia and Parapneumonic Effusion in Children. [PDF]
Complications such as parapneumonic effusion (PPE) and necrotizing pneumonia (NP) can be noted in 3% of patients with community‐acquired pneumonia and may cause functional lung damage.
Oksay SC +16 more
europepmc +3 more sources
The use of fibrinolytic therapy for parapneumonic effusion in pregnancy: a case report and a review [PDF]
The use of intrapleural fibrinolytics for complicated parapneumonic effusion has been shown to be an effective and safe alternative to surgery. However, there is limited evidence about its use during pregnancy.
Awrad Nasralla +2 more
doaj +3 more sources
Pleural Fluid Biomarkers of Pediatric Parapneumonic Effusion [PDF]
Background/Objectives: Parapneumonic pleural effusion (PPE) secondary to community-acquired pneumonia is the most common cause of pediatric pleural effusion.
Jose D. Santotoribio +5 more
doaj +3 more sources
Context Parapneumonic effusion and empyema are commonly encountered by the pulmonologist. The decision regarding management is still challenging.
Mervat A Abou Ismail +3 more
doaj +2 more sources
Efficacy of standardizing fibrinolytic therapy for parapneumonic effusion. [PDF]
While chest tube placement with pleural fibrinolytic medication is the established treatment of pediatric empyema, treatment failure is reported in up to 20% of these children. Standardizing fibrinolytic administration among interventional radiology (IR)
James CA +10 more
europepmc +2 more sources
Hemothorax With White-Out Lung After Intrapleural Tissue Plasminogen Activator and Deoxyribonuclease Therapy in a Patient With Complicated Parapneumonic Effusion. [PDF]
Tissue plasminogen activator (tPA) and recombinant deoxyribonuclease (DNase ) are used in treating pleural infection due to their mucolytic activity by effectively reducing pleural fluid viscosity.
Mainali A +6 more
europepmc +2 more sources
From Chest Wall Resection to Medical Management: The Continued Saga of Parapneumonic Effusion Management and Future Directions. [PDF]
Pleural space infections have been described since the time of Hippocrates and to this day remains a significant pathology. Every year in the USA approximately there are one million hospital admissions for pneumonia with 20%-40% associated with some form
Santoshi RK +4 more
europepmc +2 more sources
Firstcase of pneumonia-parapneumonic effusion due to Trichoderma longibrachiatum. [PDF]
Trichoderma longibrachiatum is a fungus belonging to the genus Trichoderma. Trichoderma longibrachiatum is not thought as a pathogenic for healthy individuals. However, it has the ability to produce toxic peptides and extracellular proteases and has been
Georgakopoulou VE +10 more
europepmc +2 more sources
Population-Based Cohort of Children With Parapneumonic Effusion and Empyema Managed With Low Rates of Pleural Drainage. [PDF]
Introduction: The most appropriate treatment for parapneumonic effusion (PPE), including empyema, is controversial. We analyzed the experience of our center and the hospitals in its reference area after adopting a more conservative approach that reduced ...
Moral L +13 more
europepmc +2 more sources

